辛伐他汀联合肠溶阿司匹林治疗短暂脑缺血发作疗效观察被引量：1

下载PDF

导出

摘要目的:辛伐他汀联合肠溶阿司匹林治疗短暂脑缺血发作(TIA)的疗效观察。方法:选择105例短暂性脑缺血发作患者,随机分成2组。治疗组55例,晚饭后服肠溶阿司匹林100mg,辛伐他汀20mg睡前服,一日一次。对照组50例,肠溶阿司匹林100mg晚餐后服,一日一次。所观察病例服药前均常规检查肝、肾功能。随访半年,定期监测肝、肾功能及血脂。结果:治疗组TIA发作次数明显减少,甚至未发作(P<0.05),对照组治疗前后差异无显著性(P>0.05)。结论:肠溶阿司匹林联合辛伐他汀可预防TIA发作。

作者韩卫坤张丽芳孟江涛马林霞

机构地区河北省荣誉军人康复医院

出处《中国民康医学》 2007年第8期253-253,273,共2页 Medical Journal of Chinese People’s Health

关键词辛伐他汀肠溶阿司匹林短暂脑缺血发作治疗

分类号 R743.31 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献3

1史旭波,胡大一.他汀类药物的非降脂作用[J].中国民康医学,2006,18(9):334-335. 被引量：17
2胡海鹰,李玉明.他汀类药物作用机制研究进展[J].心血管病学进展,2006,27(4):508-511. 被引量：23
3张文斌,宋筱筱,傅国胜,蔡思宇.他汀类药物临床研究进展[J].心血管病学进展,2006,27(1):79-82. 被引量：40

二级参考文献44

1Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes:a randomised placebo-controlled trial[J]. Lancet ,2003,361:2005-2016.
2Sever PS,Dahlof B, Poulter NR,et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) : a multicenter randomized controlled trial[J]. Lancet,2003,361:1149-1158.
3Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention[J]. Circulation ,2003,107:363-369.
4Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Med,2002,347:1557-1565.
5Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy Americau women[J]. Circulation,2003,107:391-397.
6Ridker PM, Rifai N, Pfeffer M, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein[ J]. Circulation, 1999,100:230-235.
7Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels. The Pravastatin Inflammation/CRP Evaluation(PRINCE) :a randomized trial and cohort study[J]. JAMA,2001,286:64-70.
8Strandberg TE,Vanhanen H,Tikkanen M J, Association between change in C-reactive protein and serum lipids during statin treatment[J]. Ann Med,2000,32 :579-583.
9van Wissert S, Trip MD, Smilde TJ, et al. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy [J]. Atherosclerosis ,2002,165:361-366.
10Ridker PM ,Rifai N ,Pfeffer MA ,et al. Inflammation ,pravastatin ,and the risk of coronary events after myocardial infarction in patients with average cholesterol levels[J]. Circulation, 1998,98:839-844.